04.04.2018 14:00:00

Equicare Health releases latest version of their product, Equicare CS 4.8

VANCOUVER, April 4, 2018 /CNW/ - Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, officially releases the latest version of their product, Equicare CS (ECS) 4.8.

"Version 4.8 has been certified for MIPS ACI 2015 Edition and supports integration with Elekta's Mosaiq 2.6 and Varian's ARIA 15.5.  We've also introduced new tools for managing Tumor Board meetings, as well as a complete refresh of our Oncology Patient Education Library," says Malcolm Wright, VP of Product Management at Equicare Health.   

ECS 4.8 includes a new Case Finding feature, as well as charting improvements that make it easier for providers to organize patient assessment and encounter notes.

For more information on the new release, please contact Equicare to learn more.

About Equicare Health
Equicare Health is the industry's leading provider of comprehensive care coordination solutions. Equicare's flagship solution EQUICARE CS™ (ECS) is a Multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a number of other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc.. In additional to the clinical toolset, Equicare offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc... ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. www.equicarehealth.com

Cision View original content:http://www.prnewswire.com/news-releases/equicare-health-releases-latest-version-of-their-product-equicare-cs-48-300623596.html

SOURCE Equicare Health Inc.

Nachrichten zu 1347 Property Insurance Holdings Incmehr Nachrichten

Keine Nachrichten verfügbar.

Analysen zu 1347 Property Insurance Holdings Incmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

ABB Ltd. (Asea Brown Boveri Ltd.) (Spons. ADRS) 54,13 0,30% ABB Ltd. (Asea Brown Boveri Ltd.) (Spons. ADRS)
Ecopetrol SA (spons. ADRs) 7,44 0,54% Ecopetrol SA  (spons. ADRs)